No Link Found Between Heart Attack Risk And Low-Dose Estrogen Contraceptives

September 14, 1998

DALLAS, Sept. 15 -- Women taking low-dose estrogen oral contraceptives may not face an increased heart attack risk, say scientists in a study in today's Circulation: Journal of the American Heart Association.

"When it comes to heart attacks, the study indicates that this type of oral contraceptive is basically safe for healthy women," says Stephen Sidney, M.D., assistant director for clinical research at the division of research, Kaiser Permanente Medical Care Program, Northern California, based in Oakland. The researchers also found no differences between women taking pills containing either of the two forms of the hormone progestin commonly used in current oral contraceptives.

There has been concern about the potential increased risk of cardiovascular disease associated with taking "the pill" since oral contraceptives were introduced in the 1960s, says Sidney.

"Although several, but not all, of the early studies showed evidence of increased risk of heart attack, most recent studies have not found the same results," notes Sidney.

Furthermore, says Sidney, contraceptive formulations have changed over the years, and newer pills contain different amounts of estrogen and progestin than earlier versions. So whether the current generation of oral contraceptives -- which have less than half the estrogen of the older preparations -- would have similar effects on the risk of heart attack has been unknown.

In 1991 the National Institute of Child Health and Human Development funded dual investigations at Kaiser Permanente and at the University of Washington at Seattle to determine the relationship between current oral contraceptives and risk of heart attack. The current analysis pooled the results of both research groups, studying 271 women between the ages of 18-44 who had heart attacks and 993 women of similar age who had not suffered a heart attack.

After the researchers adjusted for heart disease risk factors such as smoking, obesity and high blood levels of cholesterol -- thereby focusing only on the use of oral contraceptives -- women who took birth control pills were no more likely to be at risk for heart attack than women who had previously taken the pill or had never used oral contraceptives, says Sidney.

About 68 percent of the women who had heart attacks were smokers, while smokers made up only about 22 percent of those who did not have a heart attack. The mean body mass index -- a measure of a person's percent of body fat and an indication of obesity -- of the women who had heart attacks was above 30, compared to 25.5 in the women who did not have heart attacks. The National Center for Health Statistics defines overweight as a BMI of 25-29 and obesity is defined as a BMI of 30 or greater.

Researchers concluded that the women who had heart attacks were also more likely to be smokers or obese or have other risk factors for heart disease, and that it was these risk factors, not the pill, that were responsible for their risk of heart attack.

Sidney's co-authors include: David S. Siscovick, M.D.; Diana B. Petitti, M.D.; Stephen M. Schwartz, Ph.D.; Charles P. Quesenberry, Ph.D.; Bruce M. Psaty, M.D., Ph.D.; Trivellore E. Raghunathan, Ph.D.; Joseph Keleghan, M.D.; and Thomas D. Koepsell, M.D.

American Heart Association

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to